Results of a Phase I dose-escalating study of the antiangiogenic agent, SU5416, in patients with advanced malignancies. (Q44136733)
Jump to navigation
Jump to search
scientific article published in September 2002
Language | Label | Description | Also known as |
---|---|---|---|
English | Results of a Phase I dose-escalating study of the antiangiogenic agent, SU5416, in patients with advanced malignancies. |
scientific article published in September 2002 |
Statements
Results of a Phase I dose-escalating study of the antiangiogenic agent, SU5416, in patients with advanced malignancies (English)
Alison Stopeck
Marrae Sheldon
Mahmood Vahedian
Gillian Cropp
Rishi Gosalia
Alison Hannah
1 September 2002